Russell Frank Company’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Russell Frank Company’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$1.86M	Sell	53,484 -12,745	-19%	-$468K	﹤0.01%	1891
2015 Q4	$2.85M	Buy	66,229 +5,842	+10%	+$293K	0.01%	1620
2015 Q3	$2.63M	Buy	60,387 +33,701	+126%	+$1.82M	﹤0.01%	1682
2015 Q2	$1.38M	Sell	26,686 -15,643	-37%	-$667K	﹤0.01%	2166
2015 Q1	$1.66M	Sell	42,329 -4,871	-10%	-$191K	﹤0.01%	1889
2014 Q4	$1.8M	Buy	47,200 +43,010	+1,026%	+$1.64M	﹤0.01%	1850
2014 Q3	$148K	Buy	+4,190	New	+$123K	﹤0.01%	2591
2013 Q3	–	Sell	-30	Closed	–	–	3501
2013 Q2	$0	Buy	+30	New	+$483	﹤0.01%	3378

Other funds holding BSTC

ACA

Abdiel Capital Advisors New York $52M AUM 13.8% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RCMC

RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Russell Frank Company's BSTC Position: Q1 2016 in Review

Russell Frank Company reduced its BioSpecifics Technologies Corp. (BSTC) stake by 19% in Q1 2016, selling an estimated $468K and leaving 53,484 shares worth $1.86M. The position accounts for ﹤0.01% of the portfolio, ranked #1891.

Russell Frank Company first reported a position in BSTC in Q2 2013 and has held it in 8 quarters since. The position peaked at $2.85M in Q4 2015. 91 funds tracked by Wall St. Rank hold BSTC as of Q1 2016.

Russell Frank Company held 53,484 shares of BioSpecifics Technologies Corp. worth $1.86M as of Q1 2016.
Russell Frank Company sold 12,745 BioSpecifics Technologies Corp. shares in Q1 2016, an estimated $468K.
BioSpecifics Technologies Corp. made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #1891 holding.
Russell Frank Company first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and has held it in 8 quarters since.
Russell Frank Company's BioSpecifics Technologies Corp. position peaked at $2.85M in Q4 2015.
91 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.